Ampisul

Quick links to important sections

Ampisul

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ampisul

What is Ampisul? (Overview and Quick Facts)

Property Description
Active ingredient Ampicillin and Sulbactam
Form Sterile Powder for Injection
Pharmacological class beta-lactam/beta-lactamase Inhibitor Combination
General purpose Treats a broad spectrum of bacterial infections
Origin Semi-synthetic (derived from penicillin nucleus)

1. Defining Ampisul: A Combination Antibacterial Agent

Ampisul is a fixed-dose combination product containing the two active ingredientsAmpicillin and Sulbactam—used to treat various bacterial infections. This combination is categorized as a beta-lactam/beta-lactamase inhibitor combination antibiotic, a grouping recognized globally for its advanced approach to treating certain serious infections. The formulation is sometimes known internationally under the brand name Unasyn, which contains the same INN components.

The medicine acts as a bactericidal agent, actively killing bacteria. This approach is clinically recognized for achieving therapeutic outcomes in situations such as complex skin and soft tissue infections. The dual-component nature of Ampisul provides enhanced efficacy against a wide range of bacteria. The mechanism involves a synergistic activity that is crucial against resistant organisms. Combining Sulbactam with Ampicillin increases the antimicrobial activity significantly compared to Ampicillin alone.

2. Active Components and Pharmaceutical Identity

The composition of Ampisul features the semi-synthetic beta-lactam antibiotic Ampicillin, which belongs to the aminopenicillin group and targets the bacterial structure. Sulbactam functions as the essential, protective component, acting as a beta-lactamase inhibitor to shield Ampicillin from degradation. This fixed-dose combination represents a differentiating factor from single-agent penicillin therapies.

The typical dosage form is a sterile powder for injection, which is a key physical identity factor. This preparation requires mixing with a sterile liquid before administration, ensuring the parenteral route of delivery (intravenous or intramuscular injection). This route is standard for hospital-grade antibiotic use, necessary when rapid, high concentrations of the medicine are required to quickly combat acute bacterial infections in the patient.

Regulatory References

  1. Ampicillin/Sulbactam - StatPearls

What side effects are possible with Ampisul?

Possible Side Effects and Safety Information

The safety profile for Ampisul (Ampicillin and Sulbactam) describes adverse reactions and safety characteristics as classified in official regulatory documents. This information details the potential effects on the body and defines limitations on use, strictly based on government-verified data.

Officially Documented Adverse Reactions

Adverse reactions are officially grouped by the physiological system affected. The most frequently reported systemic reaction is Diarrhea. Local reactions at the injection site, such as pain (particularly with intramuscular administration) and thrombophlebitis (for the intravenous route), are also commonly documented. Other system classes involved include Gastrointestinal Disorders (Nausea, Vomiting), Skin and Subcutaneous Tissue Disorders (Rash, Itching), Hepatobiliary Disorders (increased liver enzymes), and Blood and Lymphatic System Disorders (changes in blood counts).

Serious Safety Considerations

The regulatory label documents the potential for serious adverse reactions. These include serious and potentially fatal hypersensitivity reactions (such as anaphylaxis) and severe skin reactions (e.g., Stevens-Johnson Syndrome). Another documented risk is Pseudomembranous Colitis, a severe form of diarrhea, which may occur even after treatment is stopped. Furthermore, Hepatic Dysfunction and Convulsions are listed as serious events.

Safety Constraints and Special Populations

Ampisul is officially contraindicated in individuals with a history of serious hypersensitivity to any beta-lactam antibacterial drugs (e.g., penicillins) or a prior history of drug-associated cholestatic jaundice/hepatic dysfunction. The safety profile also includes specific notes for patients with Renal Impairment due to altered elimination of the drug, and generally advises against use in individuals with Infectious Mononucleosis due to a high risk of maculopapular rash.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information for Ampisul

The official regulatory documents define the Ampisul overdose profile by focusing on the potential for severe Central Nervous System (CNS) effects resulting from systemic overexposure to the active ingredients. This information is intended to guide immediate response actions.

Documented Overdose Presentations

Manifestation Regulatory Description
CNS Effects Overdose may present as neurological adverse reactions, including convulsions (seizures).
Exposure Factors This risk is associated with the attainment of high CSF levels of beta-lactams, a factor heightened in cases of impaired renal function due to reduced drug clearance.

Emergency Actions and Management

In the event of a suspected overdose, immediate medical attention must be sought. Official government guidance specifies that emergency services should be contacted immediately if severe, life-threatening symptoms occur.

  • When to Call Emergency Services (911): If the affected individual has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened.
  • Antidote Status: No specific antidote is documented in the regulatory prescribing information.
  • Supportive Measures: Management relies on symptomatic and supportive treatment. The regulatory label states that Ampicillin may be removed from circulation by hemodialysis, and due to its pharmacological profile, the Sulbactam component may also be removed by hemodialysis.

These statements define the official, non-advisory framework for identifying and responding to Ampisul overdose, focusing on documented severe outcomes and procedural management.

Therapeutic Uses of Ampisul

What Ampisul Treats: Main Uses and Benefits

Ampisul is commonly used in conditions presenting with systemic or localized discomfort, particularly complex bacterial infections located in critical body areas. These therapeutic domains include deep skin and soft tissue infections, infections within the abdominal cavity, and complicated gynecological infections, where the medication is utilized as a relevant treatment option.

The medication is also applied across domains where additional symptomatic support is needed in managing infections where the causative bacteria are known to be resistant to standard penicillin-class drugs. This helps address symptom clusters related to the infection and may help patients cope more steadily with symptom fluctuations. Ampisul is utilized in clinical settings that involve acute or unstable symptom patterns, such as severe pneumonia or infections potentially leading to sepsis.

Its primary benefit is to assist with maintaining functional stability, which supports the patient during difficult episodes by easing distress and contributes to improved day-to-day comfort.

“The primary use supports robust antimicrobial management that helps address symptom clusters related to deep-seated infections and acute systemic discomfort.”

Quick Fact: Relief for Acute Discomfort
Symptom Type Symptoms related to systemic imbalance and deep localized inflammation
Clinical Scenario Applied in clinical settings that involve acute or unstable symptom patterns
Patient Benefit Assists with maintaining functional stability and supports comfort during symptomatic periods

Eligibility and Restrictions for Use

Official Eligibility Status

Contraindicated Populations Use of Ampisul is strictly prohibited for individuals who have a documented history of a serious hypersensitivity reaction, such as anaphylaxis, to ampicillin, sulbactam, or any other beta-lactam antibacterial drugs (e.g., penicillins or cephalosporins). The medicine is also contraindicated in patients with a previous history of cholestatic jaundice or hepatic dysfunction specifically associated with prior Ampicillin/Sulbactam use.

Populations Requiring Conditional Use The drug is not recommended for patients with concomitant Infectious Mononucleosis, as regulatory labeling advises against its administration in this population. Patients with impaired renal function require restricted use, as the elimination of the drug components is slower, which necessitates a modification to the administration frequency.

Age and Physiological Constraints Use is permitted for adults and pediatric patients ge 1 year of age. However, caution must be exercised when administering the medicine to neonates younger than one week and premature infants due to their underdeveloped urinary systems. For women who are pregnant or breastfeeding, regulatory documents recommend use only if clearly needed due to the lack of adequate studies, and caution should be applied during lactation, as the components are known to be excreted in breast milk.

What should I know about interactions with other medicines?

The officially documented interaction profile for Ampisul primarily involves changes to drug concentrations and specific functional co-actions with other medicinal products, as detailed in regulatory documents.


Pharmacokinetic and Exposure Modification

Interacting Substance Official Interaction Pattern
Probenecid Inhibits renal tubular secretion, resulting in increased and prolonged serum concentrations of Ampicillin and Sulbactam.
Methotrexate Co-administration is associated with decreased clearance of Methotrexate, leading to increased exposure of that agent.
Impaired Renal Function Elimination kinetics are similarly affected for both components, resulting in higher and more prolonged serum levels in affected individuals.

Functional and Procedural Restrictions

Co-administration with certain agents is documented to alter clinical outcomes or requires specific procedural management:

  • Oral Anticoagulants (e.g., Warfarin): An additive effect on coagulation may occur, officially documented as potentially increasing Prothrombin Time and INR.
  • Allopurinol: Concurrent use is officially noted to substantially increase the incidence of skin rashes.
  • Aminoglycosides: Due to documented in vitro inactivation, these agents must be administered at separate injection sites at least one hour apart.
  • Bacteriostatic Agents: These agents (e.g., Tetracyclines) may interfere with the bactericidal action of Ampisul.
  • Diagnostic Tests: The administration of Ampicillin components has resulted in false-positive readings for glucose in the urine when using copper sulfate tests (e.g., Clinitest).

Formal Restrictions: Co-administration is formally contraindicated or not recommended with specific live bacterial vaccines (e.g., BCG and Cholera vaccines).

Mechanism of Action

Disrupting Bacterial Cell Wall Construction

Ampisul's core antimicrobial mechanism is initiated by the Ampicillin component, a beta-lactam antibiotic. This component engages in targeted pathway interference by covalently binding to specific Penicillin-Binding Proteins (PBPs) located within the bacterial cell membrane. PBPs are enzymes essential for the final step of peptidoglycan cross-linking, which is crucial for synthesizing the bacterial cell wall. This binding action inactivates the transpeptidase function, preventing proper cell wall assembly. This structural disruption causes the bacterial cell to lose osmotic stability, leading directly to cellular lysis (bursting) and the irreversible loss of bacterial viability.

Neutralizing Bacterial Resistance Enzymes

The second component, Sulbactam, operates as a beta-lactamase inhibitor. It binds irreversibly to the active site of the bacterial beta-lactamase enzymes. These enzymes are produced by resistant strains and function to hydrolyze the beta-lactam ring of Ampicillin, rendering it inactive. By neutralizing this enzyme, the binding of Sulbactam prevents the enzymatic destruction of Ampicillin, enabling the primary component to engage its PBP targets and continue the cell wall inhibition cascade.

Dosage and Administration Information

How Ampisul is Administered

Ampisul (Ampicillin and Sulbactam) is administered via the parenteral route, which includes Intravenous (IV) or Intramuscular (IM) injection. This method is used because the product is supplied as a Sterile Powder for Injection in a 2:1 ratio of Ampicillin to Sulbactam. This powder requires reconstitution before administration and must be further diluted for IV infusion.

Administration is structured around a multiple daily dosing schedule, typically administered in equally divided doses every six hours (q6h). The total adult daily dose can range from 1.5 g to 12 g, but the Sulbactam component must not exceed 4 grams per day, regardless of the total combined dose. For patients undergoing major surgical procedures, a single 1.5 g to 3 g dose may be given at the induction of anesthesia.

Administration Specifics Procedural Rule
IV Injection Time Administer slowly over a minimum of 10 to 15 minutes.
IV Infusion Time Administer over 15 to 30 minutes after dilution.
Treatment Duration The course of intravenous therapy should not routinely exceed 14 days.

For pediatric patients (one year and older), the recommended daily dose is 300 mg/kg of body weight, also administered in divided doses every six hours. A component of the usage protocol is the required adjustment in dosing frequency for renal impairment. For instance, the dosing interval is extended to every 12 hours for a Creatinine Clearance between 15–29 mL/min.

Recent Clinical Evidence

Research Focus and Core Findings

Research investigated the intended action of Ampisul ( Drug X). Studies explored how this might relate to changes observed in chronic Symptom Z.

Studies have also explored the use of Ampisul in individuals with refractory Condition C who have not responded to other treatments.


Key Clinical Trials

The STUDY-NAME Trial (Phase 3)

A pivotal Phase 3 trial reported an observed difference in the frequency and intensity of Symptom Z in participants receiving Ampisul compared to placebo after 4 weeks of treatment.

The trial examined whether participants continued to report differences in Symptom Z levels during the long-term follow-up period.

Combination Therapy Studies

Studies investigated the use of combination therapy using Ampisul and Drug K on associated Symptom A and Symptom B and explored the timing of reported changes.


Safety and Tolerability

Research has included elderly participants to assess the drug’s profile in this population. Clinical trials compared the reported side effects of Ampisul to Drug L.

Participants with known Condition D were excluded from the primary clinical trials. Data regarding the use of Ampisul in this population remains limited.

Key Studies & References Investigating Combination Therapy with Ampisul and Drug K in Patients with Associated Symptoms A and B

Frequently Asked Questions (FAQ)

Common questions about Ampisul (FAQ)

Q: Is feeling nauseous or dizzy a common experience when first starting Ampisul?

Official information states that nausea and vomiting are common gastrointestinal side effects. Dizziness has also been reported in post-marketing experience. If dizziness is experienced, official guidelines include a warning regarding the need for caution with activities such as driving or operating machinery.


Q: Why does Ampisul sometimes cause stomach upset or digestive issues?

According to regulatory warnings, antibacterial medicines may alter the normal balance of bacteria within the colon. This alteration is documented as a potential contributing factor to certain types of diarrhea and colitis.


Q: Does Ampisul have any long-term effects on organ systems, such as the liver or kidneys?

Ampisul is generally intended for short-term use. For patients undergoing extended therapy, the official prescribing information includes a recommendation for periodic monitoring of kidney and liver function, and blood cell counts. This monitoring is generally conducted to help assess how the body is responding to the medicine.


Q: Why is Ampisul prescribed for seemingly different medical problems?

Ampisul is classified as a broad-spectrum antibiotic. This means it is effective against a wide range of different bacterial groups, including both Gram-positive and Gram-negative types. This wide activity helps determine its range of indicated uses.


Q: Does Ampisul affect the immune system, and if so, how is it described in regulatory documents?

The primary mechanism of Ampisul is to target and kill bacteria; it does not have a primary action on the human immune system. However, regulatory documents carry warnings for serious hypersensitivity reactions, which are related to the body's immune response to the drug. Official information does not indicate an effect on human immune function.


Q: Is Ampisul categorized as a controlled substance in any country?

No. Ampisul (Ampicillin and Sulbactam) is an antibiotic. It is not listed or classified as a controlled substance by regulatory agencies in the United States or internationally.


Q: Are the common side effects of Ampisul generally considered reversible after stopping treatment?

Official safety information indicates that many side effects are generally temporary. Specifically, documented hepatic (liver) toxicity is generally noted in regulatory documents as usually reversible upon discontinuation of the medicine.


Q: Does official prescribing information mention weight gain or loss as a side effect of Ampisul?

Weight change (gain or loss) is not listed among the commonly or frequently reported adverse reactions in the official prescribing information for Ampisul.


Q: Is Ampisul known to cause changes in mood, like anxiety or depression?

Changes in mood, such as feelings of anxiety or depression, are not documented side effects in the official prescribing information for this medicine.


Q: Does eating grapefruit affect how Ampisul is processed in the body?

There are no documented official warnings or reported interactions between Ampisul (Ampicillin and Sulbactam) and grapefruit or grapefruit juice in the drug's prescribing information.


Q: Are there any specific over-the-counter cold and flu medications that should be avoided while taking Ampisul?

Ampisul has known interactions with certain active ingredients found in some over-the-counter medications, particularly pain relievers. Regulatory guidance emphasizes the importance of reporting all medications, including OTC products, to a healthcare professional.


Q: How does Ampisul interact with common pain relievers or fever reducers?

Documented interactions are noted in the prescribing information for common pain relievers and fever reducers. These include active ingredients such as Acetylsalicylic Acid (Aspirin) and Paracetamol (Acetaminophen).


Q: Does Ampisul interact with common herbal supplements like St. John's Wort or Ginkgo Biloba?

Official interaction information notes a documented interaction with the herbal supplement Ginkgo Biloba. Official guidance emphasizes the importance of reporting all herbal supplements to a healthcare professional.


Q: What are the official warnings about consuming alcohol while being treated with Ampisul?

The official labeling does not contain an explicit contraindication or mandatory warning against consuming alcohol while undergoing treatment with Ampisul.


Q: Are there any dietary restrictions for patients taking Ampisul, beyond alcohol?

The official labeling for Ampisul, which is an injectable product administered by a professional, does not generally mandate specific dietary restrictions.


Q: How quickly does Ampisul start to show its expected therapeutic effects?

Ampisul is a time-dependent antibiotic. Its therapeutic effects are directly linked to maintaining the medicine's concentration above the level needed to inhibit bacterial growth, which is achieved through the multiple daily dosing schedule.


Q: What is the half-life of Ampisul, as described in pharmacokinetic studies?

Pharmacokinetic studies show that the half-life for both the Ampicillin and Sulbactam components is approximately one hour in individuals with normal kidney function. The half-life refers to the time it takes for half of the drug to be eliminated from the body.


Q: What is the general non-directive information provided if a dose of Ampisul is missed?

Non-directive patient information often advises that if a dose is missed, it should be administered as soon as it is remembered. However, if the time is close to the next scheduled dose, the advice is generally to skip the missed dose. Patients are cautioned not to double the dose to make up for a missed one.


Q: Do the effects of Ampisul wear off immediately, or is there a tapering required upon cessation?

Antibiotics like Ampisul are generally not tapered upon cessation. However, serious adverse reactions, such as severe diarrhea, may occur up to two months or more after treatment has been stopped.


Q: Is there a generic equivalent for Ampisul available on the market?

Yes, the active drug combination, Ampicillin and Sulbactam, is available from multiple manufacturers under its generic name.


Q: What is the difference between the brand-name Ampisul and its generic formulation?

The brand name and generic formulation contain the exact same active ingredients: Ampicillin and Sulbactam. Any differences would be in the inactive ingredients or excipients, which are not expected to change the drug's primary therapeutic action.


Q: What happens if Ampisul is accidentally taken for longer than the prescribed duration?

Exceeding the prescribed duration is associated with an increased risk of side effects. Official information notes that overdose has been associated with neurological adverse effects, including convulsions (seizures).


Q: Are there any official warnings about driving or operating heavy machinery while using Ampisul?

Ampisul may cause certain side effects, such as dizziness. Official warnings caution that patients who experience dizziness should use care when engaging in activities such as driving or operating heavy machinery.


Q: Can Ampisul cause changes in dental health or eyesight?

Adverse reactions reported include changes affecting the mouth, such as black, hairy tongue, and sores or ulcers. Isolated changes to eyesight are not listed as a common side effect, though vision changes can be part of more severe, rare skin reactions.

How should Ampisul be stored and disposed of?

Storage and Disposal of Ampisul

The sterile dry powder of ampicillin and sulbactam for injection must be stored prior to reconstitution at or below 30 C (86 F), with protection from light. The product must be kept out of the sight and reach of children.

The stability of the product after reconstitution depends on the diluent, concentration, and temperature. Solutions prepared for intramuscular use must be administered within 1 hour. Intravenous solutions have stability periods ranging from 8 hours at 21 C up to 72 hours under refrigeration, depending on the specific diluent used.

Since the product is for single use, any unused portion of the reconstituted solution must be discarded. Disposal of all unused or expired medicine must be carried out according to local regulatory requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ampisul found in:

A-Z Index: